Blog
RSS FeedPosted by Michael Wonder on 06 Feb 2019
FDA finalises new policy to encourage widespread innovation and development of new buprenorphine treatments for opioid use disorder
6 February 2019 - Today, the U.S. FDA issued a final guidance, “Opioid Use Disorder: Developing Buprenorphine Depot Products for Treatment,” ...
Posted by Michael Wonder on 24 Jan 2019
Ottawa’s push for lower drug costs may hurt patients, stunt innovation
24 January 2019 - The federal government’s plan to lower prescription drug prices could impede access and thus limit the ...
Posted by Michael Wonder on 24 Jan 2019
Toward an effective innovation agenda
23 January 2019 - Digital technologies have transformed the U.S. and global economies, offering tremendous benefits to consumers and financial success ...
Posted by Michael Wonder on 21 Jan 2019
New agreement on branded drugs for the NHS
18 January 2019 - The new Voluntary Scheme for Branded Medicines Pricing and Access began on 1 January and was ...
Posted by Michael Wonder on 15 Jan 2019
Would drug price controls kill innovation?
14 January 2019 - Affordability doesn’t need to come at the expense of innovation. ...
Posted by Michael Wonder on 11 Jan 2019
Regeneron CEO: ‘we need a carrot-and-stick system’ to balance pricing and innovation
10 January 2019 - Amid ongoing furore over prescription drug pricing, Regeneron Pharmaceuticals chief executive Len Schleifer has sometimes gleefully ...
Posted by Michael Wonder on 07 Jan 2019
2018: a year of innovation, efficiency, and new advances in drug therapy for the American public
7 January 2019 - The beginning of a new year is a good opportunity to look back over the past ...
Posted by Michael Wonder on 18 Dec 2018
Statement from FDA Commissioner and Director of the Center for Devices and Radiological Health on new steps to promote innovations in medical devices that help advance patient safety
18 December 2018 - Spurring innovation of medical products so that patients can have access to safe, effective treatments that ...
Posted by Michael Wonder on 12 Dec 2018
Bernie Sanders' drug price controls would stifle medical innovation
11 December 2018 - Senator Bernie Sanders and Representative Ro Khanna recently proposed bills that would impose price controls on ...
Posted by Michael Wonder on 07 Dec 2018
Underuse of innovative medicines in Germany: A justification for government intervention?
6 December 2018 - The German market for innovative medicines is characterised by simultaneous underuse and overuse. ...
Posted by Michael Wonder on 06 Dec 2018
Why regulators must move with the science if we’re to get innovative new treatments to patients more quickly
5 December 2018 - Professor Paul Workman, discusses the findings of the ICR's new drug access report, which asks how we ...
Posted by Michael Wonder on 04 Dec 2018
Flexibility on cancer drugs approval will foster innovation
4 December 2018 - Between 2000 and 2016, no new drugs were approved for cancers of the brain, and there were ...
Posted by Michael Wonder on 10 Oct 2018
New drugs: how much are governments paying for innovation?
10 October 2018 - The medical innovation debate is also heated up due to the ongoing discussion on Health Technology Assessments. ...
Posted by Michael Wonder on 03 Oct 2018
CMS accelerates innovation and promotes patient access to medical technology
3 October 2018 - Reforms to Medicare’s Local Coverage Determination process will increase transparency and patient engagement in order to ...
Posted by Michael Wonder on 02 Oct 2018
This startup wants to score you cheap prescription drugs. Now it's offering home delivery.
2 October 2018 - Digital health startup Blink Health will now provide customers free home delivery for its prescription drug ...